Search
Close this search box.

Ascendiant Capital Markets, LLC

Corporate Finance

See Our Impact

Ascendiant has led or participated in over $2.5 billion in financing transactions.

Corporate Finance

Ascendiant Capital Markets provides equity capital, debt financing, and related strategic guidance and advisory services to public and private companies, while generating investment opportunities for institutional, accredited, and strategic investors. Ascendiant’s Investment Banking division also assists private companies interested in going public.

Ascendiant has led or participated in over $2.5 billion in financing transactions across a wide range of industry sectors.

Ascendiant’s Investment Banking team has a broad network of capital providers that include investment funds, hedge funds, asset managers, senior and mezzanine lenders, family offices, sovereign wealth funds, trading firms, and fund advisors. The principals of Ascendiant manage two in-house fund entities: Ascendiant Capital Fund, LP and Ascendiant Focus Fund, LP.

Ascendiant’s senior-level Investment Bankers have expertise in all aspects of a company’s capital structure, and have provided all flavors of equity capital and debt financing including common and preferred stock, convertible debentures, bridge loans, senior and subordinated debt, and warrants.

In addition, the members of Ascendiant’s Investment Banking team have held executive and operational roles within public and private companies, giving them valuable perspective and insight.

Services include:

  • Private Placements of Equity and Equity-Linked Securities
  • Registered Direct Offerings
  • Underwritten Offerings (IPOs, Follow-Ons, Rights Offerings, At-the-Market Offerings)
  • Debt Financing (Bridge Loans, Senior and Subordinated Debt Placement)
  • Strategic business and financial advisory services
 
 
Contact Us
Our Latest Financing Transactions

$21,340,000

At-the-Market Offering

Sole Sales Agent

October

2024

$6,500,000

At-the-Market Offering

Sole Sales Agent

October

2024

$1,075,000

At-the-Market Offering

Sole Sales Agent

September

2024

$2,600,000

At-the-Market Offering

Sole Sales Agent

September

2024

$2,510,000

Private Placement

Financial Advisor

September

2024

$50,000,000

At-the-Market Offering

Sole Sales Agent

September

2024

$3,150,000

Private Placement

Sole Placement Agent

August

2024

Image001 2

$8,250,000

Private Placement

Sole Placement Agent

August

2024

$3,100,000

At-the-Market Offering

Sole Sales Agent

August

2024

$2,020,000

At-the-Market Offering

Sole Sales Agent

July

2024

$1,080,000

At-the-Market Offering

Sole Sales Agent

June

2024

$2,500,000

Public Offering

Financial Advisor

June

2024

$30,000,000

At-the-Market Offering

Sole Sales Agent

May

2024

$7,500,000

At-the-Market Offering

Sole Sales Agent

May

2024

Verb Logo

$12,765,000

At-the-Market Offering

Sole Sales Agent

May

2024

$20,000,000

At-the-Market Offering

Sole Sales Agent

May

2024

AIRTINC

$8,000,000

At-The-Market Offering

Sole Sales Agent

April

2024

Verb Logo

$9,010,000

At-the-Market Offering

Sole Sales Agent

March

2024

$947,000

At-the-Market Offering

Sole Sales Agent

March

2024

$3,300,000

Private Placement

Sole Placement Agent

February

2024

Endra Life Science

$6,200,000

At-the-Market Offering

Sole Sales Agent

February

2024

Get To Know Us

Meet the team that makes everything happen. Putting our clients first, and making sure they are successful, is what drives us each and every day. 

Meet The Team
Bradley Wilhite

Bradley J. Wilhite

Co-Founder & Managing Partner

Leadership, Investment Banking

ASCENDiant Mark

Mark A. Bergendahl

Co-Founder & Managing Partner

Leadership
Our Values

Our Values

01/08

Relationships

We’re in the money business, but we’re really in the people business. Investing in long-term relationships with clients is a fundamental principle of our business strategy, and one of the most rewarding and enjoyable aspects of what we do.

Our Values

02/08

Trust

Trust, along with excellent communication, is essential in any relationship. We value honesty, integrity, transparency, and reliability, and pledge to always do our best to earn your trust.

Our Values

03/08

Highest Standards

We’re not here to sell you, we’re here to serve you. That means doing what is best for your company and your shareholders – based on your needs and objectives, not ours. We’ve run businesses, too, and now we run an investment bank – that will always put you first.

Our Values

04/08

Serve Clients

Our goal is not to be the biggest bank, it’s to be the best – for the clients we serve. Your best financial partner, your best advisor, your best strategist, your best resource, your best sounding board. The best an investment bank has to offer.

Our Values

05/08

Success

Here’s our simple business philosophy and formula for success – maximize relationships, not fees. Success for us is a client achieving its goals and realizing its potential. When our capital is structured in a way that truly meets your needs – and allows you to hire more employees, open a new building, expand R&D, sell more product, or secure a strategic acquisition, that’s our measure of success.

Our Values

06/08

Experience

Most investors and bankers you meet have never run a business, and even fewer have managed a public company. We have unique perspective and insight from your side of the desk because we’ve been there. We appreciate what you do – tackling challenges and pursuing opportunities – and want to do our best to support you. Let our experience and expertise help you make the best decisions for your company.

Our Values

07/08

Freedom

A public company needs support from a lot of sources to achieve success. That means multiple investors, analysts, shareholders, and yes, investment banks. In short, you need a lot of investment bank friends, not just one. When an investment bank requires exclusivity or a right of first refusal following a capital raise, they are leveraging the relationship and limiting your company’s options. When you work with us, you have freedom, and that’s best for your business.

Our Values

08/08

Respect

Some investment banks are run like a money printing machine – deal after deal, and fees on top of fees. You get calls, e-mails, and texts all hours of the day, night, and weekends, pushing you to accept an offer. That’s not our style, and we’re respectful of your time and your life away from the office. We’ll listen to your needs and objectives, present ideas and solutions, and let you make the call.
Ascendiant News
October 28, 2024
Ascendiant Capital Markets LLC Serves as Sole Sales Agent on $21,340,000 At-the-Market (ATM) Offering for Giftify, Inc. (Nasdaq: GIFT)
October 10, 2024
Ascendiant Initiates Equity Research Coverage on GRI Bio, Inc. (Nasdaq: GRI)
October 7, 2024
Ascendiant Capital Markets LLC Serves as Sole Sales Agent on $6,500,000 At-the-Market (ATM) Offering for Alzamend Neuro, Inc. (Nasdaq: ALZN)
September 30, 2024
Ascendiant Capital Markets LLC announced today the filing of a $1,075,000 At-the-Market (ATM) Offering for Aclarion, Inc. (Nasdaq: ACON) of Broomfield, Colorado
September 16, 2024
Ascendiant Capital Markets LLC Serves as Sole Sales Agent on $2,600,000 At-the-Market (ATM) Offering for Auddia Inc. (Nasdaq: AUUD)
September 12, 2024
Ascendiant Serves as Financial Advisor on $2,510,000 Private Placement for Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS)
September 9, 2024
Ascendiant Capital Markets LLC’s At-the-Market (ATM) Offering for Allarity Therapeutics, Inc. (Nasdaq: ALLR) Increased to $50,000,000
September 3, 2024
Ascendiant Completes 23rd Year in Business, Moves Forward Into Year 24
August 26, 2024
Ascendiant Capital Markets LLC Serves as Sole Placement Agent on $3,150,000 Private Placement for Allarity Therapeutics, Inc. (Nasdaq: ALLR)
August 19, 2024
Ascendiant Capital Markets LLC Serves as Sole Placement Agent on $8,250,000 Private Placement for Quantum Computing Inc. (Nasdaq: QUBT)
August 12, 2024
Ascendiant Capital Markets LLC’s At-the-Market (ATM) Offering for The Singing Machine Company, Inc. (Nasdaq: MICS) Increased to $3,100,000
August 5, 2024
Ascendiant Initiates Equity Research Coverage on MIRA Pharmaceuticals, Inc. (Nasdaq: MIRA)